International Conference on
Drug Delivery and Formulations

Dr. Rahul R. Panchal is an innovator, entrepreneurial, and savvy business professional with a strong background and experience in the area of medical device development including but not limited to disposable, implantable, surgical, drug delivery devices.he is the founder and president of Leonine Technologies Inc.

He is an inventor of “multivariate shrinkage sensor (MVSS)” technology and currently pursuing the commercial development of MVSS technology under National Science Foundation (NSF)’s small business innovation research (SBIR) grant program.

Paresh Vadgama has over 12 years of R&D experience of in the areas of liquid and lyophilized drug product development (vials, PFS and cartridges) for a spectrum of Biologicals (insulin(s), peptides, PEGylated proteins, mAbs, fusion proteins & bi-specific Abs). In his current role as the Formulation and Drug product development lead at AC Immune SA, Switzerland, he is responsible for CMC development of AC Immune’s NBE and NCE portfolios. Paresh has worked previously with several biotech/pharma companies across Asia and Europe such as Glenmark, Biocon (India & Malaysia), Lupin and Intas. He has overseen early to late-stage drug product development of multiple biosimilar and NBE programs spread across PoC to Phase 1, 2, and 3. He holds a Master’s degree in Pharmaceutical Sciences with specialization in Drug Delivery from the prestigious Institute of Chemical Technology, India. His research interest includes high protein concentration formulation development, lyophilization cycle design and development, use of Quality by Design (QbD) concepts in process designing including CFD supported fill-finish operations and drug delivery device development for personalized medicines.

Dr. Md. Faiyazuddin is a renowned Edupreneurs, academician & researcher with expertise in the field of Pharmaceutical Nanotechnology. Currently, he is the Principal at Tetri Chandravansi Pharmacy College, Ramchandra Chandravansi University, Jharkhand. He is the Founder President- International Pharma Forum, and Global Business Director (Asia region) at Nano Drug Delivery®, Baltimore MD, USA.

Principal at Tetri Chandravansi Pharmacy College, Ramchandra Chandravansi University, Jharkhand Nanoplatform for potential molecules for lungs delivery, preparation and characterization of targetspecific drug delivery systems for gastrointestinal tract infections, oral delivery of cytotoxic drugs for solid tumors in novel biodegradable polymeric nanoparticles, nanocarriers for skin delivery, herbal nanoconjugates for hepatoprotection.

Sunil Kumar Panda, PhD, is currently serving as Director of Research & Development at Menovo Pharmaceuticals (Shanghai stock exchange enlisted company) in the People’s Republic of China. He has rich research work experience in formulation and development with top Indian pharmaceutical companies such as Zydus Cadila Healthcare, Dr. Reddy’s Laboratories, Jubilant, and Unichem Laboratories limited. He is an academic consultant to the Government College of Engineering and Technology, Bhubaneswar, India. With 14 years of research experience in India and abroad, he has received many international grants for pursuing his research. He is listed as a foreign research expert in the People’s Republic of China.

His professional research work has focused on complex formulation, and in particular, he has looked at multi-unit particle systems (MUPS), extended release dosage forms, and Nano suspension. He holds a World Intellectual Property Organization patent on delayed-release suspension and has published several international papers in peer-reviewed journals. His current research work involves 505 b (2) and Para IV invalidation for products in the USA market.